TOP > Success Stories > EMD Millipore Corporation

Success Stories

Polyclonal Anti-MafK/NF-E2 Antibody

Dr Kazuhiko Igarashi et al, Graduate School of Medicine, Tohoku University, generated polyclonal antibody against transcription factor MafK protein during their research focusing on gene expression system. This antibody may be useful for the research on gene regulatory networks and the phenomena such as tumorigenesis, blood cell differentiation and immune system in which MafK protein is involved. The technologies related to such antibody was transferred to and then commercialized by EMD Millipore Corporation.

For more detail, please access to EMD Millipore Corporation's Website

photo

Western Blotting Analysis:
Representative blot data.
Mouse erythroleukemia (MEL) cell lysate was probed with Cat. No. ABE1928, Anti-MafK/Nfe2u (1:2,000 dilution).
Proteins were visualized using a Donkey Anti-Rabbit IgG secondary antibody conjugated to HRP and a chemiluminescence detection system.
Arrow indicates MafK/Nfe2u (~18 kDa).

* The figure here is only permitted to use for and in this page by EMD Millipore Corporation.

Back Success Stories List

Page TOP